Belpointe Asset Management LLC Haemonetics Corp Transaction History

Belpointe Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$72.75 - $90.6 $13,095 - $16,307	180 Added 65.45%	455 $37,000
Q4 2022 Feb 08, 2023	BUY	$73.85 - $86.14 $20,308 - $23,688	275 New	275 $21,000
Q4 2018 Mar 06, 2019	SELL	$90.66 - $116.63 $910,317 - $1.17 Million	-10,041 Closed	0 $0
Q3 2018 Nov 23, 2018	BUY	$89.96 - $114.58 $17,272 - $21,999	192 Added 1.95%	10,041 $1.15 Million
Q2 2018 Aug 06, 2018	BUY	$71.53 - $95.75 $10,944 - $14,649	153 Added 1.58%	9,849 $883,000
Q1 2018 Aug 06, 2018	BUY	$60.72 - $74.41 $588,741 - $721,479	9,696 New	9,696 $709,000

333

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.21B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Belpointe Asset Management LLC with notifications on news.